These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7216479)

  • 1. Antibacterial and antitoxin responses in the serum and milk of cholera patients.
    Majumdar AS; Dutta P; Dutta D; Ghose AC
    Infect Immun; 1981 Apr; 32(1):1-8. PubMed ID: 7216479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the biological properties of different classes of human antibodies in relation to cholera.
    Majumdar AS; Ghose AC
    Infect Immun; 1981 Apr; 32(1):9-14. PubMed ID: 7216497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME; Brero ML; Mateo NA
    Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.
    Jertborn M; Svennerholm AM; Holmgren J
    J Clin Microbiol; 1986 Aug; 24(2):203-9. PubMed ID: 3528211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
    Yang JS; An SJ; Jang MS; Song M; Han SH
    PLoS One; 2019; 14(3):e0213507. PubMed ID: 30845262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
    Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
    J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
    Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP
    J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
    Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
    Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
    Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
    J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibacterial and antitoxin responses in clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection.
    Nandy RK; Albert MJ; Ghose AC
    Vaccine; 1996 Aug; 14(12):1137-42. PubMed ID: 8911010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of epidemic cholera in a previously uninfected island population: evaluation of a new seroepidemiologic method.
    Harris JR; Holmberg SD; Parker RD; Kay DE; Barrett TJ; Young CR; Levine MM; Blake PA
    Am J Epidemiol; 1986 Mar; 123(3):424-30. PubMed ID: 3946388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic specificity of neutralizing antibody to cholera toxin.
    Peterson JW; Hejtmancik KE; Markel DE; Craig JP; Kurosky A
    Infect Immun; 1979 Jun; 24(3):774-9. PubMed ID: 89089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of immunoglobulin M memory to both a T-cell-independent and a T-cell-dependent antigen following infection with Vibrio cholerae O1 in Bangladesh.
    Kendall EA; Tarique AA; Hossain A; Alam MM; Arifuzzaman M; Akhtar N; Chowdhury F; Khan AI; Larocque RC; Harris JB; Ryan ET; Qadri F; Calderwood SB
    Infect Immun; 2010 Jan; 78(1):253-9. PubMed ID: 19858296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1.
    Qadri F; Wennerås C; Albert MJ; Hossain J; Mannoor K; Begum YA; Mohi G; Salam MA; Sack RB; Svennerholm AM
    Infect Immun; 1997 Sep; 65(9):3571-6. PubMed ID: 9284121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau.
    Qureshi K; Mølbak K; Sandström A; Kofoed PE; Rodrigues A; Dias F; Aaby P; Svennerholm AM
    Pediatr Infect Dis J; 2006 Dec; 25(12):1163-6. PubMed ID: 17133163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.
    Qadri F; Ryan ET; Faruque AS; Ahmed F; Khan AI; Islam MM; Akramuzzaman SM; Sack DA; Calderwood SB
    Infect Immun; 2003 Aug; 71(8):4808-14. PubMed ID: 12874365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in the intestinal fluid during convalescence.
    Chongsa-Nguan M; Chaicumpa W; Kalambaheti T; Surachedchai Y; Thanungkul B
    Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):33-8. PubMed ID: 3660066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of anticoagulants for serologic assays of cholera vaccination.
    Yang JS; Kang SS; Yun CH; Han SH
    Clin Vaccine Immunol; 2014 Jun; 21(6):854-8. PubMed ID: 24717970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.